Walgreens Boots Alliance Inc (WBA) Position Reduced by Creative Planning

Creative Planning trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.8% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 196,073 shares of the pharmacy operator’s stock after selling 16,572 shares during the period. Creative Planning’s holdings in Walgreens Boots Alliance were worth $12,406,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the stock. Brooks Moore & Associates Inc. grew its position in Walgreens Boots Alliance by 8.0% during the first quarter. Brooks Moore & Associates Inc. now owns 30,378 shares of the pharmacy operator’s stock worth $1,922,000 after buying an additional 2,250 shares in the last quarter. Steinberg Global Asset Management bought a new stake in Walgreens Boots Alliance during the first quarter worth about $201,000. Uncommon Cents Investing LLC lifted its stake in Walgreens Boots Alliance by 7.0% during the first quarter. Uncommon Cents Investing LLC now owns 29,828 shares of the pharmacy operator’s stock worth $1,887,000 after purchasing an additional 1,950 shares during the last quarter. Ellis Investment Partners LLC bought a new stake in Walgreens Boots Alliance during the first quarter worth about $90,000. Finally, Oppenheimer & Co. Inc. lifted its stake in Walgreens Boots Alliance by 14.6% during the first quarter. Oppenheimer & Co. Inc. now owns 33,929 shares of the pharmacy operator’s stock worth $2,147,000 after purchasing an additional 4,310 shares during the last quarter. Institutional investors and hedge funds own 64.98% of the company’s stock.

In related news, COO Ornella Barra bought 18,000 shares of the stock in a transaction dated Wednesday, April 3rd. The stock was bought at an average price of $54.56 per share, with a total value of $982,080.00. Following the purchase, the chief operating officer now owns 26,425 shares in the company, valued at approximately $1,441,748. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 15.73% of the company’s stock.

NASDAQ WBA opened at $52.85 on Friday. Walgreens Boots Alliance Inc has a 1-year low of $52.25 and a 1-year high of $86.31. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The stock has a market capitalization of $48.32 billion, a PE ratio of 8.78, a P/E/G ratio of 1.08 and a beta of 0.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The company had revenue of $34.53 billion during the quarter, compared to the consensus estimate of $34.57 billion. During the same period last year, the firm posted $1.73 EPS. The company’s revenue was up 4.6% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.33%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

WBA has been the subject of several research analyst reports. Loop Capital set a $82.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 23rd. TheStreet lowered Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Friday, March 29th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 5th. Barclays dropped their price target on Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 3rd. Finally, BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, February 14th. Five investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have issued a buy rating to the stock. Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $68.00.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance Inc (WBA) Position Reduced by Creative Planning” was originally published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.baseballdailydigest.com/news/2019/04/27/walgreens-boots-alliance-inc-wba-position-reduced-by-creative-planning.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: What Are Cryptocurrencies?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.